5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States.
about
Interactions between genes and environmental factors in asthma and atopy: new developmentsAssociation studies for asthma and atopic diseases: a comprehensive review of the literatureWhat we know about nonsteroidal anti-inflammatory drug hypersensitivityPolymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approachAspirin-sensitive asthmaSerum interleukin-5 in aspirin-induced asthmaGenetic markers for differentiating aspirin-hypersensitivityA functional polymorphism in the promoter region of the cyclooxygenase-2 gene is not associated with asthma and atopy in an Australian populationA new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugsG-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveGenome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma.Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children.Recent developments in the genetics of asthma.Personalised prescribing for asthma--is pharmacogenetics the answer?Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthmaAssociation of Leukotriene C4 Synthase A-444C Polymorphism with Asthma and Asthma Phenotypes in Romanian Population.Pharmacogenetics of aspirin-intolerant asthma.Update on recent advances in the management of aspirin exacerbated respiratory disease.Severe asthma: from characteristics to phenotypes to endotypes.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Unraveling the genetic basis of aspirin hypersensitivity in asthma beyond arachidonate pathways.Pharmacogenetics of asthma in childrenGenetic mechanisms in aspirin-exacerbated respiratory disease.Genetic association analysis of TAP1 and TAP2 polymorphisms with aspirin exacerbated respiratory disease and its FEV1 decline.Leukotriene synthesis is increased by transcriptional up-regulation of 5-lipoxygenase, leukotriene A4 hydrolase, and leukotriene C4 synthase in asthmatic children.Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.Association of IL-13, RANTES, and leukotriene C4 synthase gene promoter polymorphisms with asthma and/or atopy in African Americans.Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthmaPhysiopathology and genetics in aspirin-exacerbated respiratory disease.Arg16Gly β2-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease.Genetic variants in arachidonic acid pathway genes associated with NSAID-exacerbated respiratory disease.
P2860
Q24799143-4309DF9F-00BA-4A64-9E1E-E2F77B1C1A5FQ24802474-0EF4E93A-60B8-4324-B643-88B9CAF7BC5BQ26749250-CC142406-22E4-48DC-AD93-8F32085B1940Q28171243-9D7B942A-5A71-4FC6-B00C-FE59C85F86EBQ28174122-934F53AF-DF75-4425-AB18-94940A733078Q28186724-FDDB0E7F-C9F5-417C-9D52-DC8A788BC198Q28195398-1B2389E0-7F70-477B-BEA9-8EE7FF4A25D4Q28210185-0AE0DD16-C8D8-4664-B814-A660C8F37031Q28211974-ED50CF77-7B3B-4571-89B1-3E71E410C982Q28212087-2CEBA644-1CA5-4D0B-8A96-2089227319ECQ30396182-C68CA6C5-8DA0-4EA9-9445-7370D80E1C3EQ33864878-0D5CC96E-C348-4B5E-A6F9-100B6AEF8079Q34448286-4037DD1B-B87D-48AF-9F2D-F0940AEA9347Q35118280-48B491BB-AD6C-4B41-B42F-583D1237FC4CQ35535893-82674E78-6BD6-4F19-967B-A4CFC6BB1B0FQ36301489-82367DE4-9979-4A1A-B768-C4CBC486E93FQ37043508-2CDF6067-611F-4904-B571-1A4BDECBD586Q37485583-E84D6313-2C28-4F90-9DA5-D23DAE617A9AQ37976476-C1CF239D-E827-4FBF-AB36-27197DD00DAAQ38103710-072A5F29-D9E0-423F-999E-CB556C3CB2F9Q38134073-44A5BD0E-0D12-42AD-8FD4-61A11CE34FB6Q39383921-9651E8D4-FE6A-4D8C-9FA0-8CBD3D92F4EFQ39718340-9A37E638-07E6-4AFE-93A9-A4CA1A47AEAFQ42728692-7C0FDC7C-2B1B-4876-8054-F257EFF478CDQ44452637-52607209-2129-4FF6-942C-0E1DCAFF029DQ46034358-78061729-BCC0-4619-A9D7-C2508FFB50E0Q46604953-535B033D-2A3D-43C8-8DC3-018859ECBB01Q46990378-9FA6B741-5236-4660-97A1-34C8BA24786DQ47649225-A082A42F-F2C8-43EC-877B-9697C574ACA9Q51427854-9A295C79-7B9C-489D-A08D-582346FC9F81Q51622794-3A80FB86-68F7-4ABF-982E-585BF49D2D54
P2860
5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
5' flanking region polymorphis ...... henotype in the United States.
@en
type
label
5' flanking region polymorphis ...... henotype in the United States.
@en
prefLabel
5' flanking region polymorphis ...... henotype in the United States.
@en
P2093
P921
P356
P1476
5' flanking region polymorphis ...... henotype in the United States.
@en
P2093
Baldasaro M
Penrose JF
Stevenson DD
Van Sambeek R
P356
10.1067/MAI.2000.107603
P407
P433
P577
2000-07-01T00:00:00Z